ArticleHuman vaccines & immunotherapeutics2021

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines.

Emanuelle B Gaspar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.